Evolent Health, Inc. (NYSE:EVH) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Evolent Health, Inc. earnings conference call for the first quarter ended March 31, 2025. As a reminder, this conference call is being recorded.
Evolent Health Inc. (EVH)
Market is closed
Sector: Services-Management Services
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 570,880 | $5,406,234 | -1% | 0.06% |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 330,810 | $3,132,771 | +30% | 0.03% |
| 3. | 2,665,000 | $2,171,750 | +240% | 0.02% | |
| 4. | Levin Capital Strategies John A. Levin | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.33 | 2,735 | Director | 70,584 | 2025-03-06 | Filing | |
| $9.01 | 11,040 | Officer | 389,004 | 2025-03-06 | Filing | |
| $9.09 | 15,000 | Director | 15,000 | 2025-03-07 | Filing | |
| $9.16 | 15,000 | Director | 15,000 | 2025-03-07 | Filing | |
| $9.01 | 11,040 | Director | 18,749 | 2025-03-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.00 | 4,000 | Officer | 188,340 | 2024-08-23 | Filing | |
| $32.00 | 6,469 | Officer | 192,340 | 2024-08-23 | Filing | |
| $33.00 | 7,000 | Officer | 198,809 | 2024-08-22 | Filing | |
| $30.00 | 16,693 | Officer | 205,809 | 2024-08-22 | Filing | |
| $30.00 | 16,887 | Officer | 167,027 | 2024-08-22 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,938,156 | $103,584,338 | 0% | |
| 2. | 9,229,054 | $87,399,140 | 0% | |
| 3. | 4,403,937 | $41,705,283 | 0.12% | |
| 4. | 43,477 | $35,556,794 | 1.38% | |
| 5. | 2,836,402 | $26,860,727 | 0% |
News See All
12 Stocks That Are About to Explode
Despite the current headwinds and uncertainty (which also caused heightened volatility in the last 2 weeks), there are indications that the recent US stock market correction was short-lived, and the market...
Here’s What Challenged Evolent Health (EVH) Despite Strong Revenue Growth
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Evolent Health, Inc. (NYSE:EVH) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the Fourth Quarter and Year End December 31, 2024. [Operator Instructions] As a reminder, this conference call is being recorded.
10 Stocks That Will Bounce Back According To Hedge Funds
With 2024 coming to a close, investors have left several unknown variables behind them. They started out the year wondering when and if the Federal Reserve would start cutting interest rates.
10 Best Small-Cap Stocks Ready To Explode
On October 7, Chuck Royce, founder and Senior Advisor, and Francis Gannon, Co-Chief Investment Officer and Managing Director of Royce Investment, discussed the outperformance of small-cap stocks.
Evolent Health, Inc. (NYSE:EVH) Q3 2024 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the Third Quarter Ended September 30, 2024. As a reminder, this conference call is being recorded.
Here’s Why Evolent Health (EVH) is on the List of Bottom Securities of Carillon Eagle Small Cap Growth Fund
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Oppenheimer's Favorite Stocks For Next 12 Months: Top 32 Stock Picks
The tail end of August is appearing to turn a fresh page for Wall Street.
Evolent Health, Inc. (NYSE:EVH) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the Second Quarter Ended June 30, 2024. As a reminder, this conference call is being recorded.